-
-
-
-
-
-
-
ChromaDex (CDXC) Appoints Ann Cohen and Kristin Patrick to its Board
-
-
-
-
-
-
-
ChromaDex (CDXC) Says Nicotinamide Riboside Shown in Published Research to Improve Mitochondrial Energy Production and Memory in Alzheimer’s Disease Research
-
-
-
-
-
-
-
ChromaDex to Present at the 2017 BIO Investor Forum
-
-
-
-
-
-
-
ChromaDex Partners with Asia’s Leading Health and Beauty Retailer, Watsons, for TRU NIAGEN™ Retail Launch
-
-
-
-
-
-
-
ChromaDex (CDXC) Appoints Dr. Rudolph Tanzi, Harvard Neurology Professor to Scientific Advisory Board
-
-
-
-
-
-
-
ChromaDex Reports First Quarter 2017 Financial Results
-
-
-
-
-
-
-
ChromaDex Reports 2016 Record Revenue as Ingredient Sales Grew 34%
-
1,122,779 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

